Literature DB >> 11712024

Immunofluorescence in dermatology.

D F Mutasim1, B B Adams.   

Abstract

The accurate diagnosis of bullous and other immune diseases of the skin requires evaluation of clinical, histologic, and immunofluorescence findings. Immunofluorescence testing is invaluable in confirming a diagnosis that is suspected by clinical or histologic examination. This is especially true in subepidermal bullous diseases that often have overlap in the clinical and histologic findings. Direct immunofluorescence is performed on perilesional skin for patients with bullous diseases and lesional skin for patients with connective tissue diseases and vasculitis.

Entities:  

Mesh:

Year:  2001        PMID: 11712024     DOI: 10.1067/mjd.2001.117518

Source DB:  PubMed          Journal:  J Am Acad Dermatol        ISSN: 0190-9622            Impact factor:   11.527


  23 in total

1.  A practical approach to treating autoimmune bullous disorders with systemic medications.

Authors:  Anne Han
Journal:  J Clin Aesthet Dermatol       Date:  2009-05

Review 2.  Diagnosis and clinical features of pemphigus foliaceus.

Authors:  Kirk A James; Donna A Culton; Luis A Diaz
Journal:  Dermatol Clin       Date:  2011-07       Impact factor: 3.478

3.  Usefulness of skin immunofluorescence for distinguishing SLE from SLE-like renal lesions: a pilot study.

Authors:  Ines L'Erario; Alessandra Frezzolini; Barbara Ruggiero; Ornella De Pità; Francesco Emma; Alessandra Gianviti
Journal:  Pediatr Nephrol       Date:  2010-10-13       Impact factor: 3.714

4.  Progressive ascending telangiectasias.

Authors:  Avanika Mahajan; Loren Zech; John R Durkin
Journal:  JAAD Case Rep       Date:  2022-06-02

5.  The utility of the DNA microarray scanner to simplify the immunofluorescence evaluation of autoimmune bullous diseases.

Authors:  Satori Iwamoto; Alex T Iwamoto; Jisun Cha; Todd Clark; Ming Lu; Catherine Breen; Jag Bhawan; Vincent Falanga
Journal:  Am J Dermatopathol       Date:  2009-05       Impact factor: 1.533

Review 6.  Pemphigus.

Authors:  Frank A Santoro; Eric T Stoopler; Victoria P Werth
Journal:  Dent Clin North Am       Date:  2013-08-12

7.  Serological diagnosis of autoimmune bullous skin diseases: prospective comparison of the BIOCHIP mosaic-based indirect immunofluorescence technique with the conventional multi-step single test strategy.

Authors:  Nina van Beek; Kristin Rentzsch; Christian Probst; Lars Komorowski; Michael Kasperkiewicz; Kai Fechner; Inga M Bloecker; Detlef Zillikens; Winfried Stöcker; Enno Schmidt
Journal:  Orphanet J Rare Dis       Date:  2012-08-09       Impact factor: 4.123

8.  Current concepts of immunofluorescence in oral mucocutaneous diseases.

Authors:  Ch Anuradha; N Malathi; S Anandan; Kt Magesh
Journal:  J Oral Maxillofac Pathol       Date:  2011-09

9.  Therapy of autoimmune bullous diseases.

Authors:  Diya F Mutasim
Journal:  Ther Clin Risk Manag       Date:  2007-03       Impact factor: 2.423

10.  Direct immunofluorescence in cutaneous vasculitis: experience from a referral hospital in India.

Authors:  Bn Nandeesh; Rajalakshmi Tirumalae
Journal:  Indian J Dermatol       Date:  2013-01       Impact factor: 1.494

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.